N-Carbamoylputrescine



Compound IDCDAMM02070
Common nameN-Carbamoylputrescine
IUPAC name4-aminobutylurea
Molecular formulaC5H13N3O

Experimental data

Retention time7.49
Adduct[M+Na]+
Actual mz154.095
Theoretical mz154.095
Error4.01
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.4722

Identifiers and class information

Inchi keyYANFYYGANIYHGI-UHFFFAOYSA-N
SmilesN=C(O)NCCCCN
SuperclassOrganic acids and derivatives
ClassCarboximidic acids and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)1
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-1
Molecular weight (mol_MW)131.177
Computed dipole moment(dipole)6.623
Total solvent accessible surface area (SASA)345.612
Hydrophobic component of SASA (FOSA)159.781
Hydrophilic component of SASA (FISA)185.831
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)531.834
Number of hydrogen bond donors (donorHB)5
Number of hydrogen bond acceptors (accptHB)3
Free energy of solvation of dipole (dip^2/V)0.0824717
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0194096
Globularity descriptor (glob)0.91853
Predicted polarizability in cubic angstroms (QPpolrz)11.919
Predicted hexadecane/gas partition coefficient (QPlogPC16)5.652
Predicted octanol/gas partition coefficient (QPlogPoct)13.368
Predicted water/gas partition coefficient (QPlogPw)13.298
Predicted octanol/water partition coefficient (QPlogPo/w)-1.773
Predicted aqueous solubility (QPlogS)1.938
Conformation-independent predicted aqueous solubility (CIQPlogS)0.997
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-2.202
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)24.114
Predicted brain/blood partition coefficient (QPlogBB)-0.808
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)18.115
Predicted skin permeability, log Kp (QPlogKp)-6.527
PM3 calculated ionization potential (IP(ev))9.358
PM3 calculated electron affinity (EA(eV))-1.021
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)-1.257
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)41.301
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)31.194
Van der Waals surface area (PSA)91.858
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O75899GABBR2GABA-B receptorT42446SEA
P48066SLC6A11GABA transporter 3T38200SEA
O75899GABBR2GABA-B receptorT42446SEA
P16278GLB1Beta-galactosidase (by homology)T73134SEA
Q05586GRIN1Glutamate NMDA receptor; GRIN1/GRIN2BT62276SEA
Q12879GRIN2AGlutamate NMDA receptor; GRIN1/GRIN2AT22285SEA
P23280CA6Carbonic anhydrase VIT06569SEA
Q9H4A4RNPEPAminopeptidase BT57818SEA
P11926ODC1Ornithine decarboxylaseT60366SEA
Q6QHF9PAOXPolyamine oxidaseT88699SEA
Q13224GRIN2BGlutamate [NMDA] receptor subunit epsilon 2T76414SEA
Q9UN88GABRQGABA(A) receptor thetaT15161SEA
P78325ADAM8Cell surface antigen MS2T95761SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T42446DI0117Depression[ICD-11: 6A70-6A7Z]O75899GABBR2
T42446DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]O75899GABBR2
T42446DI0275Multiple sclerosis[ICD-11: 8A40]O75899GABBR2
T42446DI0290Narcolepsy[ICD-11: 7A20]O75899GABBR2
T38200DI0207Indeterminate colitis[ICD-11: DD72]P48066SLC6A11
T42446DI0117Depression[ICD-11: 6A70-6A7Z]O75899GABBR2
T42446DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]O75899GABBR2
T42446DI0275Multiple sclerosis[ICD-11: 8A40]O75899GABBR2
T42446DI0290Narcolepsy[ICD-11: 7A20]O75899GABBR2
T73134DI0242Lysosomal disease[ICD-11: 5C56]P16278GLB1
T62276DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q05586GRIN1
T62276DI0182HIV-infected patients with tuberculosis[ICD-11: 1B10-1B14]Q05586GRIN1
T22285DI0306Nutritional deficiency[ICD-11: 5B50-5B71]Q12879GRIN2A
T06569DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P23280CA6
T06569DI0372Seborrhoeic dermatitis[ICD-11: EA81]P23280CA6
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T76414DI0024Alpha-1-antitrypsin deficiency[ICD-11: 5C5A]Q13224GRIN2B

Copyright © 2025